August 2026 - Page 17 of 21

ThursdayAug 06, 2026 9:10 am

QualityStocksNewsBreaks – AZIO AI Holdings (NASDAQ: AZIO) Signs Agreement Covering Up to $77 Million in NVIDIA GPU Systems

AZIO AI Holdings (NASDAQ: AZIO) announced an agreement with Power Champion Investment Limited for the purchase of up to 128 NVIDIA HGX B300 GPU systems to be deployed at U.S.-based AI infrastructure facilities. Based on an estimated midpoint price of $600,000 per system, the company said the agreement represents an approximate aggregate hardware value of $77 million if all contemplated systems are purchased, though actual revenue will depend on market pricing, delivery volumes and timing. The agreement supports the initial phase of AZIO AI’s commercial relationship with Power Champion and builds on the hosting agreement the companies announced in July. Management…

ThursdayAug 06, 2026 9:00 am

Greenland Mines Ltd. (NASDAQ: GRML) Launches Biggest Skaergaard Field Season Yet as Critical Minerals Take Center Stage

The company launches its 2026 season, designed to move its Skaergaard project into its next phase of development. Key critical minerals mined at Skaergaard, including palladium and platinum serve critical industrial functions with few viable substitutes. Skaergaard ranks among the world's largest undeveloped palladium, gold and platinum deposits, and Greenland Mines holds an 80% interest in the licenses covering it. Argus, a support vessel loaded with drill rigs, just sailed out of Reykjavik, and it is carrying more than equipment. The ship is carrying the opening move of Greenland Mines’ (NASDAQ: GRML) most ambitious field season yet at its Skaergaard project,…

WednesdayAug 05, 2026 2:40 pm

Surgeon, Payer, Patient Win: The Economic and Workflow Advantages Positioning GelrinC as a New Standard of Care for Knee Cartilage Repair

Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production yield by 400%. The company is advancing commercialization through scalable manufacturing, surgeon training programs, and continued U.S. Phase III clinical progress. These developments reinforce Regentis' strategy of bringing innovative cartilage repair technology from clinical validation to commercial scale, with unit economics that improve as production volumes build. Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC, its innovative cell-free hydrogel implant for focal knee cartilage repair, with a value proposition that extends across the entire healthcare ecosystem. Designed to simplify treatment while improving clinical outcomes,…

WednesdayAug 05, 2026 1:54 pm

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Expands Project Holdings in Prolific Abitibi Belt

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) was featured in a recent article that discussed its efforts to expand its gold project holdings in Québec’s prolific Abitibi Greenstone Belt through the acquisition of 27 mineral claims totaling approximately 701 hectares adjacent to its McKenzie East Project. The transaction increases LaFleur’s overall Abitibi land position to more than 23,100 hectares across 490 claims and adds ground containing a historical Maruska gold showing, which the company plans to explore through data compilation, drilling and other exploration activities. Meanwhile, LaFleur is…

WednesdayAug 05, 2026 1:15 pm

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Combines Targeted Cancer Therapy, Nanotechnology and AI

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is pursuing an integrated approach to cancer drug development that combines three emerging areas: PNKP-targeted DNA damage response (“DDR”) inhibition, nanoparticle drug delivery and artificial intelligence. Its lead candidate, ONC010, pairs a PNKP inhibitor with a polymer micelle carrier intended to improve drug solubility, tumor accumulation and tolerability, while the company’s Inka Health subsidiary is developing the SynoGraph causal AI platform to support patient selection, clinical trial design and evidence generation. The company is advancing ONC010 through preclinical, manufacturing and IND-enabling…

WednesdayAug 05, 2026 12:52 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Advances Telehealth Position Through Technology, Vertical Integration

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its positioning in the growing telehealth and healthcare markets through strategic investments, vertical integration and proprietary technology. Through subsidiaries such as DOConsultations LLC and Las Villas Health Care Inc., the company provides online and brick-and-mortar telehealth services focused on wellness and direct-to-patient delivery, while also targeting the expanding peptide therapy market. ETST’s in-house IT capabilities and custom technology infrastructure are designed to provide a competitive advantage by improving operational efficiency and margins across its divisions. As the company continues expanding its technology and healthcare offerings, its integrated platform…

WednesdayAug 05, 2026 12:45 pm

QualityStocksNewsBreaks – Streamex Corp. (NASDAQ: STEX) Sets Second Quarter 2026 Results, Business Update Call

Streamex (NASDAQ: STEX) announced it will report second-quarter 2026 financial results on Friday, Aug. 14, 2026, and host a conference call and webcast on Monday, Aug. 17, 2026, at 4:30 p.m. ET to discuss the results and provide a corporate update. Management said the quarter marked significant progress as the company expanded its tokenized commodities ecosystem through new product launches, strategic partnerships and infrastructure enhancements. The company highlighted milestones including the launch of a compliant decentralized secondary market for tokenized securities with Orca, institutional brokerage distribution through collaborations with Siebert and tZERO, and the appointment of Kori Handy to lead product and design. Following quarter-end, Streamex also added T+0…

WednesdayAug 05, 2026 12:36 pm

QualityStocksNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Schedules Second Quarter 2026 Results Call

Wrap Technologies (NASDAQ: WRAP) announced it will host a conference call on Tuesday, Aug. 11, 2026, at 4:30 p.m. ET to discuss financial and operational results for the second quarter ended June 30, 2026. Company management will provide an update on quarterly performance followed by a question-and-answer session. Investors may submit questions in advance by email through 5 p.m. ET on Aug. 10, with responses subject to relevance and public disclosure considerations. The company said its second-quarter 2026 earnings release and related materials will be available in the Investors section of its website before the call. Participants may join the webcast or register for dial-in access through the…

WednesdayAug 05, 2026 12:28 pm

QualityStocksNewsBreaks – Why BOXABL Inc. (NASDAQ: BXBL) Is ‘One to Watch’

BOXABL (NASDAQ: BXBL) was featured in a recent article that discussed its positioning as a technology company focused on transforming residential construction through a factory-built, modular housing system designed for scale. The publication reads, “By shifting homebuilding from traditional on-site processes to controlled manufacturing environments, the company aims to introduce a more standardized, efficient and repeatable approach to housing production. Its model integrates design, engineering and manufacturing into a unified system intended to improve speed, cost predictability and overall accessibility.” To view the full article, visit https://ibn.fm/7u9QR About BOXABL Inc. BOXABL is transforming the housing market with its modular building systems designed to…

WednesdayAug 05, 2026 12:26 pm

QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Publishes Peer-Reviewed Capture-Seq Study

VolitionRx Limited (NYSE American: VNRX) announced the publication of the first peer-reviewed paper detailing its proprietary Capture-Seq liquid biopsy technology, which the company said is the first to isolate and analyze more than 99% pure circulating tumor-derived DNA ("ctDNA"). According to the publication, the technology addresses a longstanding challenge in liquid biopsy by separating cancer-derived DNA from the large background of healthy cell-free DNA, creating highly enriched tumor DNA datasets for cancer detection and monitoring. Volition said it is conducting technical evaluations with potential licensing partners and estimates the technology addresses annual market opportunities of approximately $23 billion for multi-cancer early detection and more than $13 billion for…

Site Search

Company Search

Month: August 2026